S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

LBPH Longboard Pharmaceuticals Inc

35.95

-0.05 (-0.14%)

20 Jul 2024 - Closed

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
lbph_2022_ars.pdf

Longboard Pharmaceuticals (NASDAQ:LBPH)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Longboard Pharmaceuticals Charts.

Longboard Pharmaceuticals (NASDAQ:LBPH)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Longboard Pharmaceuticals Charts.

Longboard Pharmaceuticals, Inc. News

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Thursday 4 July 2024 (2 weeks ago) • Business Wire

Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
Monday 1 July 2024 (3 weeks ago) • Business Wire

Form 8-K - Current report
Monday 10 June 2024 (1 month ago) • Edgar (US Regulatory)

Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
Monday 10 June 2024 (1 month ago) • Business Wire

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Tuesday 4 June 2024 (2 months ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 25 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 25 May 2024 (2 months ago) • Edgar (US Regulatory)

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Tuesday 7 May 2024 (2 months ago) • Business Wire

Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Friday 3 May 2024 (3 months ago) • Business Wire

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
Thursday 4 April 2024 (4 months ago) • Business Wire

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Wednesday 3 April 2024 (4 months ago) • Business Wire

Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
Wednesday 13 March 2024 (4 months ago) • Business Wire

More Longboard Pharmaceuticals, Inc. News Articles

AUD vs US Dollar

Australian SE All Ordina...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions